Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
GCNT1
Introduction
Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase is an enzyme that in humans is encoded by the GCNT1 gene.[1][2][3]
This gene is a member of the beta-1,6-N-acetylglucosaminyltransferase gene family. It is essential to the formation of Gal beta 1-3(GlcNAc beta 1-6)GalNAc structures and the core 2 O-glycan branch. The gene coding this enzyme was originally mapped to 9q21, but was later localized to 9q13. Multiple alternatively spliced variants, encoding the same protein, have been identified.[3]
References
References
- ↑ Bierhuizen MF, Mattei MG, Fukuda M (Apr 1993). “Expression of the developmental I antigen by a cloned human cDNA encoding a member of a beta-1,6-N-acetylglucosaminyltransferase gene family”. Genes Dev. 7 (3): 468–78. doi:10.1101/gad.7.3.468. PMID 8449405.
- ↑ Yeh JC, Ong E, Fukuda M (Mar 1999). “Molecular cloning and expression of a novel beta-1, 6-N-acetylglucosaminyltransferase that forms core 2, core 4, and I branches”. J Biol Chem. 274 (5): 3215–21. doi:10.1074/jbc.274.5.3215. PMID 9915862.
- ↑ 3.0 3.1 “Entrez Gene: GCNT1 glucosaminyl (N-acetyl) transferase 1, core 2 (beta-1,6-N-acetylglucosaminyltransferase)”.
Further reading
Further reading
- Bierhuizen MF, Fukuda M (1992). “Expression cloning of a cDNA encoding UDP-GlcNAc:Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen”. Proc. Natl. Acad. Sci. U.S.A. 89 (19): 9326–330. doi:10.1073/pnas.89.19.9326. PMC 50119. PMID 1329093.
- Bierhuizen MF, Maemura K, Kudo S, Fukuda M (1995). “Genomic organization of core 2 and I branching beta-1,6-N-acetylglucosaminyltransferases. Implication for evolution of the beta-1,6-N-acetylglucosaminyltransferase gene family”. Glycobiology. 5 (4): 417–25. doi:10.1093/glycob/5.4.417. PMID 7579796.
- Skrincosky D, Kain R, El-Battari A, et al. (1997). “Altered Golgi localization of core 2 beta-1,6-N-acetylglucosaminyltransferase leads to decreased synthesis of branched O-glycans”. J. Biol. Chem. 272 (36): 22695–702. doi:10.1074/jbc.272.36.22695. PMID 9278427.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Beum PV, Bastola DR, Cheng PW (2003). “Mucin biosynthesis: epidermal growth factor downregulates core 2 enzymes in a human airway adenocarcinoma cell line”. Am. J. Respir. Cell Mol. Biol. 29 (1): 48–56. doi:10.1165/rcmb.2002-0147OC. PMID 12600830.
- Falkenberg VR, Alvarez K, Roman C, Fregien N (2004). “Multiple transcription initiation and alternative splicing in the 5′ untranslated region of the core 2 beta1-6 N-acetylglucosaminyltransferase I gene”. Glycobiology. 13 (6): 411–8. doi:10.1093/glycob/cwg039. PMID 12626388.
- Chibber R, Ben-Mahmud BM, Mann GE, et al. (2003). “Protein kinase C beta2-dependent phosphorylation of core 2 GlcNAc-T promotes leukocyte-endothelial cell adhesion: a mechanism underlying capillary occlusion in diabetic retinopathy”. Diabetes. 52 (6): 1519–27. doi:10.2337/diabetes.52.6.1519. PMID 12765965.
- Smith MJ, Smith BR, Lawrence MB, Snapp KR (2004). “Functional analysis of the combined role of the O-linked branching enzyme core 2 beta1-6-N-glucosaminyltransferase and dimerization of P-selectin glycoprotein ligand-1 in rolling on P-selectin”. J. Biol. Chem. 279 (21): 21984–91. doi:10.1074/jbc.M402731200. PMID 15026421.
- Suzuki Y, Yamashita R, Shirota M, et al. (2004). “Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions”. Genome Res. 14 (9): 1711–8. doi:10.1101/gr.2435604. PMC 515316. PMID 15342556.
- Kikuchi J, Shinohara H, Nonomura C, et al. (2005). “Not core 2 beta 1,6-N-acetylglucosaminyltransferase-2 or -3 but -1 regulates sialyl-Lewis x expression in human precursor B cells”. Glycobiology. 15 (3): 271–80. doi:10.1093/glycob/cwi005. PMID 15483269.
- Beum PV, Basma H, Bastola DR, Cheng PW (2005). “Mucin biosynthesis: upregulation of core 2 beta 1,6 N-acetylglucosaminyltransferase by retinoic acid and Th2 cytokines in a human airway epithelial cell line”. Am. J. Physiol. Lung Cell Mol. Physiol. 288 (1): L116–24. doi:10.1152/ajplung.00370.2003. PMID 15591039.
- Wang L, Mitoma J, Tsuchiya N, et al. (2005). “An A/G polymorphism of core 2 branching enzyme gene is associated with prostate cancer”. Biochem. Biophys. Res. Commun. 331 (4): 958–63. doi:10.1016/j.bbrc.2005.04.022. PMID 15882971.
- Prorok-Hamon M, Notel F, Mathieu S, et al. (2006). “N-glycans of core2 beta(1,6)-N-acetylglucosaminyltransferase-I (C2GnT-I) but not those of alpha(1,3)-fucosyltransferase-VII (FucT-VII) are required for the synthesis of functional P-selectin glycoprotein ligand-1 (PSGL-1): effects on P-, L- and E-selectin binding”. Biochem. J. 391 (Pt 3): 491–502. doi:10.1042/BJ20050344. PMC 1276950. PMID 15926890.
- Hagisawa S, Ohyama C, Takahashi T, et al. (2006). “Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression”. Glycobiology. 15 (10): 1016–24. doi:10.1093/glycob/cwi086. PMID 15932919.
- Kikuchi J, Ozaki H, Nonomura C, et al. (2005). “Transfection of antisense core 2 beta1,6-N-acetylglucosaminyltransferase-1 cDNA suppresses selectin ligand expression and tissue infiltration of B-cell precursor leukemia cells”. Leukemia. 19 (11): 1934–40. doi:10.1038/sj.leu.2403951. PMID 16179912.
- Kimura K, Wakamatsu A, Suzuki Y, et al. (2006). “Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes”. Genome Res. 16 (1): 55–65. doi:10.1101/gr.4039406. PMC 1356129. PMID 16344560.
- Cabrera PV, Amano M, Mitoma J, et al. (2006). “Haploinsufficiency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell death”. Blood. 108 (7): 2399–406. doi:10.1182/blood-2006-04-018556. PMC 1895562. PMID 16778138.
- Julien S, Grimshaw MJ, Sutton-Smith M, et al. (2007). “Sialyl-Lewis(x) on P-selectin glycoprotein ligand-1 is regulated during differentiation and maturation of dendritic cells: a mechanism involving the glycosyltransferases C2GnT1 and ST3Gal I.”. J. Immunol. 179 (9): 5701–10. doi:10.4049/jimmunol.179.9.5701. PMID 17947642.